Source: Annual Congress 2010 - Regulation of airway hyperresponsiveness and bronchodilators
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Patel, S. Marshall, S. Summerhilll, M. Strawbridge, M. Stanley, E. Stuart, M. Trevethick, M. Yeadon, N. Clarke (Sandwich, United Kingdom). The in-vitro pharmacology of PF-4522971 – A novel inhaled Muscarinic M₃ Antagonist. Eur Respir J 2010; 36: Suppl. 54, 1237

Member's Comments

No comment yet.

Related content which might interest you: The in-vitro pharmacology of PF-3429281 – A novel inhaled dual antimuscarinic/β2 adrenoceptor agonist Source: Annual Congress 2010 - Regulation of airway hyperresponsiveness and bronchodilators Year: 2010 The in vitro biology of PF-00610355 – a novel β2 adrenoceptor agonist with a long duration of action Source: Annual Congress 2009 - Models of chronic airways disease and therapy Year: 2009 Demonstration of dual pharmacology in vivo of PF-3429281: A novel inhaled dual antimuscarinic/β2 agonist Source: Annual Congress 2010 - Regulation of airway hyperresponsiveness and bronchodilators Year: 2010 PF-3429281 – A novel inhaled dual antimuscarinic/β2 adrenoceptor agonist in the anaesthetised dog model of bronchoconstriction Source: Annual Congress 2010 - Bronchodilators in airways disease Year: 2010 Treatment of sarcoidosis – pentoxifylline Source: Annual Congress 2009 - Pleural and parenchymal diseases Year: 2009 Airway resistances: Raw, sRaw, sReff – Which is the best determinant of airway function? Source: Annual Congress 2010 - Lung function from infancy to adulthood Year: 2010 Nebulized bimosiamose – anti-inflammatory pan-selectin antagonist for the treatment of COPD Source: Annual Congress 2009 - Treatment of airways disease Year: 2009 PF-00610355 – an inhaled β2 adrenoceptor agonist with superior potency and duration of action (DoA) to salmeterol in the conscious dog model of bronchoconstriction Source: Annual Congress 2009 - Models of chronic airways disease and therapy Year: 2009 Monitoring of efficacy of therapy with monoclonal antibodies – Omalizumab – Using the Recovery-ELISA Source: Annual Congress 2011 - Treatment strategies, systemic manifestations and biomarkers in airway diseases Year: 2011 Differential involvement of IκB kinases α and β in asthma and COPD Source: Annual Congress 2010 - COPD and asthma: models and human studies Year: 2010 Adrenomedullin – a protective factor in asthma? Source: Annual Congress 2009 - Animal models of airways inflammation Year: 2009 Tumor nekrozis faktor-alfa blockers and tuberculosis – Analysis of the 6 years Source: Annual Congress 2011 - Tuberculosis in immunocompromised hosts Year: 2011 Optimization of inhalation treatment – Evaluation of influence of PNEUMOlogic® and Optimiser® spacers on aerosol particle distribution from pMDI-EB Source: Annual Congress 2011 - Drug delivery and pharmacokinetics I Year: 2011 Usability evaluation of NEXThaler® versus Diskus® and Turbuhaler® Source: Annual Congress 2012 - Trials in asthma: asthma exacerbations and severe asthma Year: 2012 Oral glucocorticoid treatment of severe asthma – Current practice in the US Source: Annual Congress 2010 - Aspects of severe asthma Year: 2010 Sensitivity and specificity of airway hyperreactivity (AHR) based on methacholine challenge (MCH) tests – Comparison of sGeff with FEV1 and MEF50 as target parameter Source: Annual Congress 2012 - Bronchial challenge as a biomarker of respiratory disease Year: 2012 Over-reading spirometry – Man or machine? Source: Annual Congress 2011 - Quality control in lung function and exercise-related issues Year: 2011 Asthma medication and antibiotics – Cause or effect? Source: Annual Congress 2010 - Paediatric respiratory epidemiology: early origins of childhood asthma Year: 2010 EGFR – a useful biomarker? Source: Annual Congress 2009 - Biological and clinical markers in lung cancer Year: 2009 LungPoint® – A new approach to peripheral lung lesions Source: Annual Congress 2010 - Tissue is mostly the issue: diagnostic and therapeutic bronchoscopy Year: 2010